Drug Trial Radar · NCT05035082
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,018
Actual
Start
Sep 1, 2021
Primary completion
Jun 18, 2025
Study completion Jun 18, 2025
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Sep 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this study are tablets which lower blood sugar in people with type 2 diabetes. The purpose of the study is to see how well RYBELSUS® is at lowering blood sugar compared to other tablets when used in addition to metformin. Participants doctor will give participants either RYBELSUS® or any other blood sugar lowering tablets - which treatment participants get is decided by chance. The doctor treating participants diabetes will give participants a prescription for the medicine and tell how to take it. The study will last for about 1 year. Participants will have 2 planned visits with their doctor which are part of the usual routine diabetes management: the first visit is when participants are included in the study, the second visit is a 1-year follow-up visit. In addition, the study personnel will contact participants up to 3 times during this period and to follow-up on information from participant doctors visits. Participant will be asked to respond 3 times to 4 questionnaires via their personal smartphone or tablet or paper if participant do not have access to one during the study. All clinic visits are part of the usual routine diabetes management and are covered by participants health insurance plan. The study team will collect information from these visits recorded in the medical chart. Women cannot take part if pregnant, breast-feeding or plan to become pregnant during the study period.
Conditions
- Diabetes Mellitus, Type 2
Interventions
semaglutideDrug
Oral administration The doctor will give a prescription for the medicine and tell how to take it.
oral glucose-lowering medications (commercially available)Drug
Oral administration The doctor will give a prescription for the medicine and tell how to take it.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Glycated Haemoglobin (HbA1c)Time frame: Week 0, year 1
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Stewart Medical Group
Alhambra, California
FDRC
Costa Mesa, California
Scripps Whittier Diabetes Inst
La Jolla, California
Raincross Medical Group
Riverside, California
Reyes Clinical Research, Inc
Miami, Florida
DC Research Works
Marietta, Georgia
Urban Family Practice Assoc
Marietta, Georgia
Macoupin Research Group
Gillespie, Illinois
UnityPoint Health-Diabetes Care Center
Peoria, Illinois
Endeavor Health
Skokie, Illinois
Kernodle Clin Dpt-Pvt Diagnost
Burlington, North Carolina
OnSite Clinical Solutions, LLC_Charlotte
Charlotte, North Carolina
WakeMed Garner Hlthplx
Garner, North Carolina
Clinical Research of Gastonia
Gastonia, North Carolina
Valley Weight Loss Clinic
Fargo, North Dakota
Diab & Endo Assoc of Stark Co
Canton, Ohio
Central Ohio Clinical Research LLC
Columbus, Ohio
Jefferson Endocrinology Assocs
Philadelphia, Pennsylvania
Tristar Clin Investigations, PC
Philadelphia, Pennsylvania
Preferred Primary Care Physicians_Pittsburgh
Pittsburgh, Pennsylvania
AnMed Health IMA
Anderson, South Carolina
Baylor Scott & White Res Inst
Dallas, Texas
Hill Country Medical Associates
New Braunfels, Texas
DCT-Stone Oak
San Antonio, Texas
Chrysalis Clinical Research
St. George, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.